Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01962181|
Recruitment Status : Unknown
Verified September 2013 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : October 14, 2013
Last Update Posted : October 14, 2013
|Condition or disease||Intervention/treatment||Phase|
|"Attention Deficit Hyperactivity Disorder"||Drug: Ritalin Drug: Placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Identifying Characteristic Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment|
|Study Start Date :||October 2013|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||December 2015|
Active Comparator: Ritalin
Ritalin treatment at different doses
Patients with ADHD and healthy subjects will be examined under Ritalin or placebo
Placebo Comparator: Placebo
Two meetings, one of which will be given a placebo and the other will be given a low dose of Ritalin, randomly.
- Resting oscillation activity and Event-related-Potentials in Attention Deficit / Hyperactivity Disorder (ADHD) and healthy subjects. [ Time Frame: 2 years ]The primary outcome measure is the difference in the analysis of EEG recording (for example, resting oscillation activity and Event-related-Potentials) in Attention Deficit / Hyperactivity Disorder (ADHD) vs. healthy subjects.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01962181
|Contact: Renana Eitan, MDemail@example.com|
|Contact: Shahar Arzy, MD|
|Hadassah Medical Center|
|Jerusalem, Israel, 91000|
|Contact: Renana Eitan, MD firstname.lastname@example.org|
|Principal Investigator: Renana Eitan, MD|
|Principal Investigator:||Renana Eitan, MD||Hadassah Medical Center|